PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration

Breast cancer is the second highest incidence of cancer in the world. It is of great significance to find biomarkers to diagnose breast cancer and predict the prognosis of breast cancer patients. PAIP2 is a poly (A) -binding protein interacting protein that regulates the expression of VEGF. However,...

Full description

Bibliographic Details
Main Authors: Chenyu Wang, Xianglai Jiang, Jiaojiao Qi, Jiachao Xu, Guangfei Yang, Chengrong Mi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1009056/full
_version_ 1828134746323943424
author Chenyu Wang
Chenyu Wang
Xianglai Jiang
Jiaojiao Qi
Jiaojiao Qi
Jiachao Xu
Jiachao Xu
Guangfei Yang
Chengrong Mi
author_facet Chenyu Wang
Chenyu Wang
Xianglai Jiang
Jiaojiao Qi
Jiaojiao Qi
Jiachao Xu
Jiachao Xu
Guangfei Yang
Chengrong Mi
author_sort Chenyu Wang
collection DOAJ
description Breast cancer is the second highest incidence of cancer in the world. It is of great significance to find biomarkers to diagnose breast cancer and predict the prognosis of breast cancer patients. PAIP2 is a poly (A) -binding protein interacting protein that regulates the expression of VEGF. However, the possible role of PAIP2 in the progression of breast cancer is still unknown. RT-qRCR and Western blotting were used to verify the expression of PAIP2 in breast cancer cells and normal breast cells. The data of breast cancer samples were obtained in the TCGA database and the HPA database to analyze the expression of PAIP2 in breast cancer samples. Transwell experiment and CCK8 experiment confirmed the changes in the invasion and proliferation ability of PAIP2 after siRNA was down-regulated. Using bioinformatics technology to explore the prognostic value of PAIP2 and its possible biological function, and its effect on tumor immunity and immunotherapy. Studies have shown that PAIP2 has higher expression in breast cancer tissues and breast cancer cells. PAIP2 can promote the proliferation and invasion of breast cancer cells and has significantly high expression in higher tumor stages. The high expression of PAIP2 is associated with better OS in breast cancer patients and is negatively correlated with most chemotherapeutic drug sensitivity and IPS in cancer immunotherapy. Our study explored the potential value of PAIP2 as a biomarker for diagnosis and prognosis and may predict the efficacy of immunotherapy, providing reference for the follow-up study on the role of PAIP2 in breast cancer.
first_indexed 2024-04-11T17:39:41Z
format Article
id doaj.art-402fae47856248d8ba70bf75c343566d
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-11T17:39:41Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-402fae47856248d8ba70bf75c343566d2022-12-22T04:11:31ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-11-011310.3389/fgene.2022.10090561009056PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltrationChenyu Wang0Chenyu Wang1Xianglai Jiang2Jiaojiao Qi3Jiaojiao Qi4Jiachao Xu5Jiachao Xu6Guangfei Yang7Chengrong Mi8School of Clinical Medicine, Ningxia Medical University, Yinchuan, ChinaDepartment of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, ChinaSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, ChinaSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, ChinaDepartment of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, ChinaSchool of Clinical Medicine, Ningxia Medical University, Yinchuan, ChinaDepartment of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, ChinaDepartment of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, ChinaDepartment of Ultrasound, General Hospital of Ningxia Medical University, Yinchuan, ChinaBreast cancer is the second highest incidence of cancer in the world. It is of great significance to find biomarkers to diagnose breast cancer and predict the prognosis of breast cancer patients. PAIP2 is a poly (A) -binding protein interacting protein that regulates the expression of VEGF. However, the possible role of PAIP2 in the progression of breast cancer is still unknown. RT-qRCR and Western blotting were used to verify the expression of PAIP2 in breast cancer cells and normal breast cells. The data of breast cancer samples were obtained in the TCGA database and the HPA database to analyze the expression of PAIP2 in breast cancer samples. Transwell experiment and CCK8 experiment confirmed the changes in the invasion and proliferation ability of PAIP2 after siRNA was down-regulated. Using bioinformatics technology to explore the prognostic value of PAIP2 and its possible biological function, and its effect on tumor immunity and immunotherapy. Studies have shown that PAIP2 has higher expression in breast cancer tissues and breast cancer cells. PAIP2 can promote the proliferation and invasion of breast cancer cells and has significantly high expression in higher tumor stages. The high expression of PAIP2 is associated with better OS in breast cancer patients and is negatively correlated with most chemotherapeutic drug sensitivity and IPS in cancer immunotherapy. Our study explored the potential value of PAIP2 as a biomarker for diagnosis and prognosis and may predict the efficacy of immunotherapy, providing reference for the follow-up study on the role of PAIP2 in breast cancer.https://www.frontiersin.org/articles/10.3389/fgene.2022.1009056/fullPaip2TCGAbiomarkersbreast cancerimmune
spellingShingle Chenyu Wang
Chenyu Wang
Xianglai Jiang
Jiaojiao Qi
Jiaojiao Qi
Jiachao Xu
Jiachao Xu
Guangfei Yang
Chengrong Mi
PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
Frontiers in Genetics
Paip2
TCGA
biomarkers
breast cancer
immune
title PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
title_full PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
title_fullStr PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
title_full_unstemmed PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
title_short PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
title_sort paip2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
topic Paip2
TCGA
biomarkers
breast cancer
immune
url https://www.frontiersin.org/articles/10.3389/fgene.2022.1009056/full
work_keys_str_mv AT chenyuwang paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT chenyuwang paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT xianglaijiang paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT jiaojiaoqi paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT jiaojiaoqi paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT jiachaoxu paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT jiachaoxu paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT guangfeiyang paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration
AT chengrongmi paip2isapotentialdiagnosticandprognosticbiomarkerofbreastcancerandisassociatedwithimmuneinfiltration